Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer
Titel:
Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer
Auteur:
Patnaik, Amita Papadopoulos, Kyriakos P. Tolcher, Anthony W. Beeram, Muralidhar Urien, Saïk Schaaf, Larry J. Tahiri, Sanaa Bekaii-Saab, Tanios Lokiec, François M. Rezaï, Keyvan Buchbinder, Aby